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OBJECTIVES: Cancer in young adults represents a great challenge, both biologically and socially, and under-
standing the unique characteristics of neoplasms in this age group is important to improving care. We aimed to
evaluate the most common carcinomas and their characteristics, such as histological type and clinical stage,
in young adults in the largest cancer hospital in Latin America.
METHODS: The hospital registry was consulted for the period between 2008 and 2014. Young adults were
defined as individuals aged 18 to 39 years, and older adults were defined as individuals aged 40 years and older.
Differences between age groups were assessed through chi-square tests.
RESULTS: Of the 39,389 patients included, 3,821 (9.7%) were young adults. Among the young adults, the most
frequent cancer types were the following: breast, lymph node, colorectal, thyroid, testicle, hematopoietic and
reticuloendothelial, uterine cervix, brain, soft tissue and stomach; these sites accounted for 74.5% of the observed
tumors. Breast, colorectal and stomach cancers were more frequently diagnosed at advanced stages in young
adults than in older adults (po0.001). The most common histological types were infiltrating ductal carcinoma
(86.12%) for breast cancer, adenocarcinomas not otherwise specified (45.35%) for colorectal cancer, squamous
cell carcinoma not otherwise specified (65.26%) for uterine cervix cancer, signet ring cell adenocarcinomas
(49.32%) for stomach cancer and adenocarcinomas not otherwise specified (50.79%) for lung cancer.
CONCLUSION: Young adults are diagnosed with cancer at more advanced stages, indicating that health pro-
fessionals should be aware of cancer incidence in this age group. It is necessary to develop a better understanding
of cancer in young adults and to implement dedicated health care strategies for these patients.
KEYWORDS: Neoplasms; Young Adult; Neoplasm Staging; Histology.
’ INTRODUCTION
Cancer is one of the main health problems among young
adults (aged 20 to 39 years), and it is the second and fifth
leading causes of death in women and men, respectively, in
the USA (1). In addition, approximately 70,000 adolescents
and young adults (AYA), aged 15 to 39 years, are diagnosed
with cancer each year in the USA alone (2,3).
In young adults (YA), cancer is associated with unique
issues including increased social and psychological morbidities,
fertility preservation, schooling and work concerns, as well
as long term side effects of treatment (4,5). In addition, young
adults may be diagnosed with cancer at more advanced
stages as a consequence of delayed cancer diagnosis, or
unique biological characteristics (6). In the face of these many
challenges, some agencies have proposed recommendations
to help young adults with cancer regain a sense of control
over their lives (7).
In general, the most common cancers in AYA, aged 15 to
39 years, are Hodgkin’s lymphoma, melanoma, testicular
carcinoma, germ cell carcinoma, cervical carcinoma, thyroid
carcinoma, soft tissue sarcoma, and osteosarcoma. Some of
these cancers are uncommon in other age groups, such as
germ cell ovarian and testicular carcinomas. This distribution
contrasts with that in young children, in whom small round
cell embryonic tumors, such as neuroblastoma, Wilms’ tumor,
retinoblastoma, rhabdomyosarcoma and teratomas, are more
common. AYA neoplasms also differ from those in middle-
aged and elderly people, in whom malignancies of epithelial
cell origin or carcinomas of several primary sites account
for more than 85% of cancers (3). Nevertheless, some AYADOI: 10.6061/clinics/2018/e656s
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develop certain carcinomas that are commonly diagnosed in
older individuals but that are uncommon in AYA.
In Brazil, data from the Brazilian National Cancer Institute
(Instituto Nacional do Câncer, INCA) (8) indicate that the
most frequent neoplasms in AYA, aged 15 to 29 years, were
carcinomas of all types (34.2%), followed by lymphomas (12.1%)
and skin tumors. This study also reported a trend towards
an increase in the average annual percent change (AAPC)
during the reference period in the incidence rates of all neoplasms
in this age group in four out of the 13 population-based
cancer registries (Registros de Câncer de Base Populacional -
RCBPs), mainly due to an increase in the carcinoma inci-
dence rate, which has been observed in eight out of the
12 RCBPs. Regarding mortality rates, even though there
was no significant variation in the AAPC considering all
neoplasms in the whole reference period, there was a small
decrease in the mortality rate from 1982 to 1983, followed
by more recent increases in the mortality rate from 1992 to
1998 and from 1998 to 2013. In that study, however, data
regarding the most frequent types of carcinomas in AYA and
the clinical stages were not available.
Hence, unfortunately, in Brazil, there is a scarcity of data
regarding some types of cancer in young adults, such as
carcinomas. Our aim was to evaluate the most common
primary sites of cancer as well as the histological type and
clinical stage at diagnosis of frequent carcinomas in young
adults who were treated at a main reference cancer hos-
pital in Latin America, the Instituto do Câncer do Estado de
São Paulo (ICESP).
’ METHODS
This observational study was conducted at the ICESP in
São Paulo City, Brazil. ICESP, the largest cancer hospital in
Latin America, is integrated with the Brazilian public health
system (Sistema Único de Saúde, SUS) and delivers care to
patients referred from primary, secondary and non-oncologic
tertiary centers.
Patient data were obtained on February 1st, 2018, from the
hospital registry database. The period searched was from
May 1st, 2008, to April 30th, 2014. All patients registered at
the ICESP during that period with malignant neoplasms
(International Code of Diseases, ICD C00 – C96) were
included and considered for the evaluation of the primary
site of disease, clinical stage and histological type. Patient
gender was obtained for a subgroup of patients registered
from January 1st, 2009, to December 31st, 2013. Patients with
basal cell carcinoma and squamous cell carcinoma of the skin
and patients 17 years old or younger were excluded. The YA
included in the study were defined as individuals registered
at the ICESP with cancer who were between the ages of 18
and 39 years, and older adults (OA) included in the study
were defined as individuals 40 years old and older. Statistical
significance was calculated using chi-square tests, and
Po0.05 was considered significant.
’ RESULTS
Primary tumor site
Between May 1st, 2008, and April 30th, 2014, 39,389 indi-
viduals with malignant neoplasms were registered at the
ICESP, of whom 3,821 (9.7%) were YA (aged 18 to 39 years)
and 35,568 were OA (age X40 years). Figure 1a shows the
distribution of primary cancer sites among all patients.
Among YA, the 10 most frequent cancers were breast
cancer (n=605; 15.83%), lymphoma (n=376; 9.84%), colorectal
cancer (n=333; 8.71%), thyroid cancer (n=309; 8.09%),
testicular cancer (n=256; 6.70%), leukemia (n=245; 6.41%),
uterine cervical cancer (n=225; 5.89%), brain cancer (n=196;
5.13%), soft tissue cancers (n=154; 5.1%) and stomach cancer
(n=148; 3.87%). Tumors of these types were detected in
74.5% of the patients registered. Figure 1b summarizes these
findings.
For OA, the 10 most frequent cancers were prostate cancer
(n=6,248; 17.57%), breast cancer (n=5,352; 15.05%), colorectal
cancer (n=5,009; 14.08%), lung cancer (n=2,831; 7.96%),
stomach cancer (n=2,226; 6.26%), head and neck cancer (n=1,
994; 5.61%), bladder cancer (n=1,231; 3.46%), leukemia (n=1,
111; 3.12%), esophageal cancer (n=1,086; 3.05%) and thyroid
cancer (n=977; 2.75%). These neoplasms were present in
78.91% of the patients. Figure 1c summarizes these findings.
In a sample of 3,098 YA registered at the ICESP from
January 1st, 2009, to December 31st, 2013, the stratification of
type of cancer by gender was obtained. For YA females
(n=1,866), the following primary sites were the most fre-
quent: breast (n=468; 25%), thyroid (n=230; 12%), uterus
and/or cervix (n=164; 9%), lymph node (n=153; 8%), colon
and/or rectum (n=145; 8%), blood (n=95; 5%), brain (n=69;
4%), stomach (n=69; 4%), skin (n=67; 4%), soft tissue (n=61;
3%), ovary (n=2; 3%), lung (n=35; 2%), kidney (n=31; 2%), bone
(n=30; 2%) and pancreas (n=25; 1%). Among the YA males
(n=1,232), the most frequent primary cancer sites were as
follows: testicles (n=212; 17%), lymph node (n=175; 14%),
colon and/or rectum (n=115; 9%), brain (n=93; 9%), blood
(n=7; 7%), skin (n=63; 5%), stomach (n=58; 5%), soft tissue
(n=51; 4%), head and neck (n=46; 4%), bone (n=39; 3%),
thyroid (n=32; 3%), liver (n=30; 2%), kidney (n=30; 2%) and
heart, mediastinum and pleura (n=27; 2%). The graphs in
Figure 2 show these results.
Clinical stage
Approximately 13% (n=5,205) of the 39,389 patients included
in this study had cancers that were not classified by the
tumor-node-metastases (TNM) staging system (mostly lym-
phomas and leukemias), and 2.82% (n=1,114) had tumors of
unknown clinical stage (CS) according to the TNM staging
system. The remaining 35,335 individuals had neoplasms clas-
sified as CS 0 (n=710; 2%), CS I (n=5,375; 14%), CS II (n=9,
535; 24%), CS III (n=8,047; 20%) or CS IV (n=11,668; 30%).
Approximately half of the YAwere diagnosed with advanced
and metastatic disease (24% with CS III and 26.44% with
CS IV). In addition, 19% of the YA had tumors classified as
CS II, 26.84% had tumors classified as CS I, and 3.7% of the
YA had in situ disease (CS 0). A significantly different distri-
bution was observed in the OA, among whom only 1.88%
were diagnosed with in situ neoplasms, 14.33% had tumors
classified as CS I, 27.6% had tumors classified as CS II, 22.68%
had tumors classified as CS III and 32.52% had metastatic
disease (po0.001). These results are represented in Figure 3.
Clinical stage classification was evaluated for the follow-
ing six tumor sites that were frequently found in both the YA
and the OA: breast, colon and/or rectum, lung, stomach,
head and neck and thyroid. Compared with the OA, the YA
presented with advanced and metastatic disease (CS III and
IV) more frequently when they had breast (YA 51% vs. OA
44.1%; p=0.002), colorectal (YA 78.6% vs. 64.6%; po0.001)
and stomach tumors (YA 88.9% vs OA 74.0%; po0.001).
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Figure 1 - Cancer sites in all patients. (1A): Most frequent tumor sites (n) in all patients registered at the ICESP (May 2008 to April 2014);
(1B): Most frequent tumors (%) in YA (18 – 39 years); 1C: Most frequent tumors (%) in older patients (X40 years).
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In contrast, compared with the YA, the OA were more fre-
quently diagnosed as having cancer classified as CS III and
IV when they had thyroid cancer (YA 3.3% vs. OA 39.2%;
po0.001). Among the patients with lung cancer, the YA had
significantly more metastatic disease than the OA (YA 82.4%
vs OA 65.9%; p=0.014). No significant difference in CS at
diagnosis was found in patients with head and neck cancers.
Figure 4 and Table 1 show these results.
Histological type
The histological classifications of breast, colorectal, uterine
cervical, stomach and lung tumors were retrieved for the YA.
Among the YA with breast cancer, the most common histol-
ogical type was infiltrating ductal carcinoma (86.12%), followed
by in situ ductal carcinoma (2.81%) and lobular carcinoma
(1.82%). The most commonly diagnosed colorectal tumors
were adenocarcinomas not otherwise specified (NOS) (45.35%),
tubular adenocarcinoma (30.93%) and mucinous adenocarci-
noma (9.61%). The most common uterine cervical cancer
histological subtypes were squamous cell carcinoma NOS
(65.26%), squamous intraepithelial neoplasms grade III
(20.53%) and adenocarcinoma NOS (9.47%). In YA with
stomach neoplasms, most tumors were classified as signet
ring cell adenocarcinomas (49.32%), adenocarcinomas NOS
(19.59%) and tubular adenocarcinomas (6.08%). Finally, the
most commonly diagnosed lung cancer histological subtypes
in the YA were adenocarcinoma NOS (50.79%), squamous
cell carcinoma NOS (6.35%), undifferentiated carcinoma NOS
(6.35%) and carcinoid tumor NOS (6.35%). Table 2 summarizes
these findings.
Figure 2 - Cancer sites in young adults stratified by gender (January 2009 to December 2013). (2A): primary tumor sites (%) in young
adult females registered at the ICESP; (2B): primary tumor sites (%) in young adult males registered at the ICESP. HMP: heart,
mediastinum and pleura.
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’ DISCUSSION
Cancer in young adults represents a special challenge
for patients, family members and physicians. YA have
specific demands with regard to their medical, psychologi-
cal and social care to ensure appropriate treatment and
reintegration into their social lives and the work force (4,5).
Information regarding the most common types of neo-
plasms in YA is scarce in Brazil, and this study aimed to
evaluate the frequency of various types of cancers diagnosed
in a population from a large reference cancer hospital in
Brazil.
It is noteworthy that the incidence rates of the most
frequently treated cancers at the ICESP closely reflect the
incidence rates of those cancers in Brazil. According to the
INCA projection for 2018 (9), the most common cancers in
Brazil are prostate, breast, colorectal, lung, stomach, uterine
cervical, oral cavity, central nervous system, and esophageal
cancers as well as leukemias. The main differences between
the most common cancers in Brazil and those at the ICESP
Figure 3 - Clinical stage according to the TNM staging system. (3A): CS of all young adults (18-39 years) registered at the ICESP; (3B): CS
of all older adults registered at the ICESP (X40 years).
Figure 4 - Clinical stage according to age and tumor site.
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are that uterine cervical and central nervous system neo-
plasms are not among the 10 most frequently treated cancers
at the ICESP. In the case of uterine cervical neoplasms, this
difference might be explained by this type of cancer being
less frequently diagnosed in more developed regions, such as
São Paulo, than in the less developed regions of the country
(10). In addition, at the ICESP, thyroid and bladder cancer are
among the 10 most frequently treated cancers, even though
they are not included among the top ten most common
cancers in Brazil. It is important to point out that our study
aimed to evaluate the most frequently treated cancers in a
cancer hospital and not the national incidence rate; therefore,
this observation may reflect a selection bias due to pecu-
liarities of the study.
In 2016, the INCA published a comprehensive study focus-
ing on the incidence, mortality and hospital morbidity rates in
AYA aged 15 to 29 years (8). Incidence data were obtained from
25 out of the existing 31 RCBPs. In Brazil, the median of the
mean incidence rates for AYA (15 to 29 years old) adjusted for
age was 236.16 per million (241.74 per million in females and
212.71 per million in males) in the reference period, according
to data from 24 RCBPs. Among all tumors diagnosed, 4.3%
occurred in AYA, which is lower than our finding of 9.7%.
However, a higher age limit was adopted in our study (18 to 39
years) than in the INCA data (15 to 29 years), as we assumed
the previously adopted recommendations regarding the maxi-
mum age cutoff value for the definition of YA (4).
The most frequent neoplasms in AYA ages 15-29 years
reported by the INCA were carcinomas of all types (34.2%);
followed by lymphomas (12.1%); skin tumors, including mel-
anomas and carcinomas (9.0%); leukemias (8.0%), neoplasms
NOS (7.3%); central nervous system cancers (6.9%); germ cell
neoplasms (5.3%); soft tissue sarcomas (5.1%); bone tumors
(3.8%), and miscellaneous cancers (0.9%). These results are
in agreement with those attained using the data from the
ICESP; if we had grouped breast, colorectal, thyroid and
stomach cancer together, they would account for a total of
36.5% of all cancers.
At the ICESP, YA were generally diagnosed with less
advanced disease than older adults. This result is possibly
influenced by thyroid cancer; more than 85% of YA with
thyroid cancer are diagnosed with CS 0 and I. Furthermore,
this general finding is reversed when investigating other
carcinomas frequently found in all age groups. For breast,
colorectal, stomach and lung cancers, YA are more frequently
diagnosed with advanced and/or metastatic disease than
OA. Previous studies reported similar findings (6,11-14),
and this trend towards diagnosis at later stages may affect
the higher morbidity and mortality rates observed in YA
with carcinomas compared with OA with carcinomas.
In addition, diagnosis at an advanced stage of the disease
raises the suspicion of a delayed diagnosis due to the
underestimation of the signs and symptoms, possibly resul-
ting from the relatively low incidence of cancer in YA and a
Table 1 - Clinical stage according to tumor site and age group.
Primary tumor site CS Young adults Older adults p
N % N %
Breast 0 19 3.30 247 4.71 o0.001
I 67 11.65 954 18.21
II 196 34.09 1726 32.95
III 210 36.52 1272 24.28
IV 83 14.43 1040 19.85
Total 575 100.00 5239 100.00
Colon and/or rectum 0 2 0.64 42 0.87 o0.001
I 15 4.79 364 7.53
II 50 15.97 1302 26.95
III 131 41.85 1714 35.48
IV 115 36.74 1409 29.17
Total 313 100.00 4831 100.00
Lung 0 0 0.00 3 0.11 0.135
I 4 7.84 233 8.51
II 1 1.96 116 4.24
III 4 7.84 581 21.23
IV 42 82.35 1804 65.91
Total 51 100.00 2737 100.00
Stomach 0 1 0.79 13 0.64 o0.001
I 8 6.35 299 14.74
II 5 3.97 216 10.65
III 15 11.90 356 17.55
IV 97 76.98 1144 56.41
Total 126 100.00 2028 100.00
Head and neck 0 2 2.74 8 0.42 0.032
I 8 10.96 115 6.06
II 5 6.85 126 6.64
III 8 10.96 229 12.07
IV 50 68.49 1419 74.80
Total 73 100.00 1897 100.00
Thyroid I 275 91.36 464 49.47 o0.001
II 16 5.32 106 11.30
III 2 0.66 219 23.35
IV 8 2.66 149 15.88
Total 301 100.00 938 100.00
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low awareness among health professionals of the incidence
of cancer in this age group (5,6). For breast cancer, specifically,
age is considered a poor prognostic factor independent of
stage (13), whereas for lung cancer, YA tend to have better
prognoses in all stages compared with OA (13,14).
Regarding the histological information, patients registered
at the ICESP had similar patterns as those previously described.
Although squamous cell carcinoma was the most frequent
histological type, due to its close association with HPV infec-
tion in the uterus and cervix, the incidence of adenocarci-
noma has been increasing worldwide and accounts for 10
to 15% of cases (15). Similar proportions were found in our
population. For stomach cancer, diffuse and intestinal sub-
types are more frequently detected in YA and OA, respec-
tively (11,16). Our data substantiate this, as signet ring cell
carcinoma, a type highly associated with diffuse histology,
represented almost half of the gastric tumors diagnosed in
YA in this study. The most common histological type of lung
cancer in our study was adenocarcinoma (50.79%), followed
by squamous cell carcinoma (6.35%), which was also simi-
lar to the results of previous reports (14,17,18). In addition,
most breast tumors were infiltrating ductal carcinomas, and
only a small proportion were lobular carcinomas (1.82%).
This observation is in agreement with the findings of other
studies that demonstrated that the frequency of lobular carci-
noma is lower in young women than in older women (19,20).
Although we did not estimate incidence rates, it is interes-
ting to observe that, according to the INCA (6), the trend in
the AAPC in the incidence rates of carcinomas in the refer-
ence period in YA aged 15-29 years tended to increase in
eight out of the 12 PBCRs evaluated and to decrease in only
one PBCR. In Brazil, the mean mortality rate adjusted for age
for all neoplasms in AYAwas 66.97 per million in both sexes
(72.08 per million in males and 61.72 per million in females).
Notably, even though the AAPC in mortality rates did not vary
for all cancers, a small decrease in the period from 1982 to
1983 was observed, followed by increases in the periods from
1992 to 1998 and from 1998 to 2013.
To the best of our knowledge, this study is the first to eval-
uate the clinical stages and histological types of common car-
cinomas in YA in Brazil. The limitations of this study include
a small sample size of YA per type of cancer and the use
of a single hospital database. However, our study revealed
tumor-specific information regarding cancer in YA, which
may be valuable in the clinical setting. As YA tend to present
advanced stage carcinomas, future studies are needed to
Table 2 - Tumor histological types in young adults.
Primary tumor site Histological type N %
Breast Infiltrating ductal carcinoma 521 86.12
In situ intraductal carcinoma 17 2.81
Lobular carcinoma 11 1.82
Phyllodes malignant tumor 8 1.32
Acinic cell carcinoma 6 0.99
Others 42 6.94
Total 605 100.00
Colon and/or rectum Adenocarcinoma NOS 151 45.35
Tubular adenocarcinoma 103 30.93
Mucinous adenocarcinoma 32 9.61
Signet ring cell adenocarcinoma 11 3.30
Squamous cell carcinoma NOS 11 3.30
Neuroendocrine carcinoma NOS 10 3.00
Others 15 4.50
Total 333 100.00
Uterus and/or cervix Squamous cell carcinoma NOS 124 65.26
Squamous intraepithelial neoplasms grade III 39 20.53
Adenocarcinoma NOS 18 9.47
Squamous cell in situ NOS 11 5.79
Mucinous adenocarcinoma 5 2.63
Adenocarcinoma in situ NOS 4 2.11
Others 24 12.63
Total 190 100.00
Stomach Signet ring cell adenocarcinoma 73 49.32
Adenocarcinoma NOS 29 19.59
Tubular adenocarcinoma 9 6.08
Mucinous adenocarcinoma 7 4.73
Gastrointestinal stromal sarcomas 7 4.73
Malignant lymphoma diffuse large cell NOS 5 3.38
Others 18 12.16
Total 148 100.00
Lung Adenocarcinoma NOS 32 50.79
Squamous cell carcinoma NOS 4 6.35
Undifferentiated carcinoma NOS 4 6.35
Carcinoid tumors NOS 4 6.35
Bronchioloalveolar carcinoma NOS 3 4.76
Neuroendocrine carcinoma NOS 3 4.76
Small cell carcinoma NOS 2 3.17
Others 11 17.46
Total 63 100.00
NOS: not otherwise specified.
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investigate the reasons for the delay in diagnosis. In summary,
improved understanding of the unique characteristics of can-
cer in this age group is important to reduce its high biological,
social and psychological impacts.
Data regarding cancer in YA is still scarce. Our results
revealed that YA may be diagnosed with cancers at more
advanced stages, indicating that health professionals should
be aware of the incidence rates of neoplasms in this age
group. It is important to better understand cancer in YA and
to implement dedicated healthcare strategies addressing the
needs of these patients.
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